NewAmsterdam Pharma (NAMSW) Stock Chart & Stock Price History $13.78 +0.34 (+2.52%) As of 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock NewAmsterdam Pharma Stock Price Performance The NewAmsterdam Pharma (NAMSW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 96.84%, with a year-to-date return of -3.31%. In the past month, the stock has increased 20.18%, reflecting recent market activity. As of the latest close, NewAmsterdam Pharma traded at $13.33 with a market cap of and volume of 3,952 shares. Receive NAMSW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.15%1 Month Performance+20.18%3 Month Performance+68.65%Year-To-Date Performance-3.31%1 Year Performance+96.84% NAMSW Stock Chart for Friday, August, 22, 2025 NAMSW Chart by TradingView NewAmsterdam Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$13.69$13.33-2.60%$13.44$12.873,952 shs$0.0008/20/2025$13.41$13.69+2.09%$13.46$13.46140 shs$0.0008/19/2025$13.80$13.41-2.83%$13.81$13.474,121 shs$0.0008/18/2025$13.80$13.80$13.85$13.801,200 shs$0.0008/15/2025$13.64$13.80+1.20%$13.85$13.801,203 shs$0.0008/14/2025$14.15$13.64-3.63%$13.82$13.60820 shs$0.0008/13/2025$13.50$14.15+4.81%$14.15$14.002,233 shs$0.0008/12/2025$13.18$13.50+2.47%$13.52$13.50700 shs$0.0008/11/2025$13.87$13.18-5.01%$13.18$13.13588 shs$0.0008/08/2025$7.00$13.87+98.14%$14.17$12.2526,264 shs$0.00 Get the Latest News and Ratings for NAMSW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$12.00$7.00-41.67%$12.00$11.501,300 shs$0.0008/06/2025$10.74$12.00+11.69%$12.00$11.501,384 shs$0.0008/05/2025$12.44$10.74-13.60%$11.16$10.27938 shs$0.0008/04/2025$10.23$12.44+21.55%$10.42$10.231,100 shs$0.0008/01/2025$10.41$10.23-1.72%$10.42$10.231,100 shs$0.0007/31/2025$11.42$10.41-8.88%$11.90$10.413,471 shs$0.0007/30/2025$11.45$11.42-0.23%$11.60$10.791,312 shs$0.0007/29/2025$12.51$11.45-8.47%$11.45$11.301,303 shs$0.0007/28/2025$12.20$12.51+2.53%$12.89$12.505,039 shs$0.0007/25/2025$11.79$12.20+3.45%$12.96$11.704,157 shs$0.0007/24/2025$12.56$11.79-6.09%$13.30$11.688,484 shs$0.0007/23/2025$11.47$12.56+9.54%$13.30$11.688,484 shs$0.0007/22/2025$11.40$11.47+0.61%$11.45$11.271,303 shs$0.0007/21/2025$11.00$11.40+3.60%$11.48$11.251,784 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 60 Degrees Pharmaceuticals Stock Price Chart Alpha Tau Medical Stock Price Chart Apollomics Stock Price Chart BriaCell Therapeutics Stock Price Chart Cardio Diagnostics Stock Price Chart Celularity Stock Price Chart CERo Therapeutics Stock Price Chart Cingulate Stock Price Chart Clene Stock Price Chart Receive NAMSW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NAMSW) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access